HIGHLIGHTS
- who: Khetam Ghannam et al. from the Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Pediatric Rheumatology and Immunology, University Hospital Muenster, Muenster, Germany have published the Article: Distinct Effects of Interleukin-1 Inhibition upon Cytokine Profile in Patients with Adult-Onset Still’s Disease and Active Articular Manifestation Responding to Canakinumab, in the Journal: (JOURNAL)
- what: Since no predictive or associated markers for response to IL1 inhibitors have been established in patients with AOSD so far, this study investigated the cytokine profile in AOSD patients in more detail. As the primary outcome . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.